FERNDALE PHARMACEUTICALS LIMITED - Profile & Financials

Previous Company Names

BROOMCO (3171) LIMITED 2 Apr 2003 — 18 Jul 2003

Accounts Submitted 30 Sept 2025 Next due 30 Sept 2026 4 months remaining

Confirmation Submitted 8 Apr 2025 Next due 22 Apr 2026 2 months overdue

Net assets £4M £115K 2024 year on year

Total assets £5M £538K 2024 year on year

Total Liabilities £1M £422K 2024 year on year

Charges 1

1 satisfied

Contact & Details

Contact

Registered Address

Unit 740 Street 2 Thorp Arch Estate Wetherby West Yorkshire LS23 7FX

Telephone

0800 000 0000

info@example.com

Website

www.example.com

Full company profile for FERNDALE PHARMACEUTICALS LIMITED (04720051), an active life sciences and medical technology company based in Wetherby, United Kingdom. Incorporated 2 Apr 2003. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£3.00M

Increased by £9.78k (+0%)

Net Assets

£4.03M

Increased by £115.40k (+3%)

Total Liabilities

£1.33M

Increased by £422.46k (+47%)

Turnover

N/A

Employees

Increased by 2 (+9%)

Debt Ratio

25%

Increased by 6 (+32%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

2 active 1 resigned

Show resigned officers

						Status
James Thayer Mcmillan Ii	Director	American	United States	80	9 Sept 2003	Active
Sem Lloyd Davies	Director	British	United Kingdom	61	25 May 2011	Active

Shareholders

Shareholders (4)


Ferndale Laboratories, Inc.	76.4%
Roger Mark Bloxham	14.1%

Persons with Significant Control

Persons with Significant Control (3)

3 Active

Roger Mark Bloxham

British

Active

Notified 6 Apr 2016

Residence England

DOB June 1964

Nature of Control

Ownership Of Shares 25 To 50 Percent

Ferndale Pharma Group Inc

United States Of America

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 50 To 75 Percent

Mr Roger Mark Bloxham

British

Active

Notified 6 Apr 2016

Residence England

DOB June 1964

Nature of Control

Ownership Of Shares 25 To 50 Percent

Group Structure

FERNDALE PHARMACEUTICALS LIMITED Current Company

Charges

1 satisfied

Properties

1 leasehold 1 total

Address	Tenure	Price Paid	Date Added
Unit 124, Thorp Arch Estate, Wetherby (LS23 7BJ) LEEDS	Leasehold	-	6 Aug 2008

Unit 124, Thorp Arch Estate, Wetherby (LS23 7BJ)

Leasehold

Added 6 Aug 2008

District LEEDS

Documents

Company Filings

Date	Category	Description
30 Sept 2025	Accounts	Annual accounts made up to 31 Dec 2024
1 Aug 2025	Officers	Change to director Mr Sem Lloyd Davies on 1 Aug 2025
1 Aug 2025	Officers	Change to director Mr Christopher Stein on 1 Aug 2025
1 Aug 2025	Officers	Change to director Mr Sem Lloyd Davies on 1 Aug 2025
1 Aug 2025	Officers	Change to director Mr Christopher Stein on 1 Aug 2025

30 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

1 Aug 2025 Officers

Change to director Mr Sem Lloyd Davies on 1 Aug 2025

1 Aug 2025 Officers

Change to director Mr Christopher Stein on 1 Aug 2025

1 Aug 2025 Officers

Change to director Mr Sem Lloyd Davies on 1 Aug 2025

1 Aug 2025 Officers

Change to director Mr Christopher Stein on 1 Aug 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

7 months ago on 30 Sept 2025

Change to director Mr Sem Lloyd Davies on 1 Aug 2025

9 months ago on 1 Aug 2025

Change to director Mr Christopher Stein on 1 Aug 2025

9 months ago on 1 Aug 2025

Change to director Mr Sem Lloyd Davies on 1 Aug 2025

9 months ago on 1 Aug 2025

Change to director Mr Christopher Stein on 1 Aug 2025

9 months ago on 1 Aug 2025